Literature DB >> 10673907

Selenium supplementation affects the retention of stable isotopes of selenium in human subjects consuming diets low in selenium.

J W Finley1, A Duffield, P Ha, R A Vanderpool, C D Thomson.   

Abstract

Twenty-nine women and fifteen men from an area of low Se intake (South Island of New Zealand) consumed 100 micrograms stable 74Se, as selenate given in water after an overnight fast, and blood was collected for 3 weeks. They were then divided into five groups and supplemented with 0, 10, 20, 30 and 40 micrograms Se/d (as selenomethionine) for 5 months. After 5 months, they received a second dose of 74Se identical to the first. Supplementation significantly altered retention of 74Se in the plasma, but not in the erythrocytes or platelets. Subjects receiving the placebo retained the greatest amount, and subjects receiving 30 micrograms supplemental Se/d retained the least 74Se. Supplementation resulted in relatively more isotope being retained in a medium molecular mass protein considered to be albumin, and relatively less in another fraction considered to be selenoprotein P. The lack of many observed changes in retention of stable Se, and the shift in retention among the plasma proteins, suggests that supplemental Se was not being used to replete critical pools of Se, probably because of adaptation to low Se intake.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10673907     DOI: 10.1017/s0007114599001592

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  7 in total

1.  High-dose selenium substitution in sepsis: a prospective randomized clinical trial.

Authors:  Jiri Valenta; Helena Brodska; Tomas Drabek; Jan Hendl; Antonin Kazda
Journal:  Intensive Care Med       Date:  2011-02-24       Impact factor: 17.440

Review 2.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients.

Authors:  Vašková Janka; Kočan Ladislav; Firment Jozef; Vaško Ladislav
Journal:  Wien Klin Wochenschr       Date:  2013-05-04       Impact factor: 1.704

4.  Relevance of selenoprotein transcripts for selenium status in humans.

Authors:  Edyta Reszka; Ewa Jablonska; Jolanta Gromadzinska; Wojciech Wasowicz
Journal:  Genes Nutr       Date:  2011-09-07       Impact factor: 5.523

Review 5.  Selenium and Metabolic Disorders: An Emphasis on Type 2 Diabetes Risk.

Authors:  Ashley N Ogawa-Wong; Marla J Berry; Lucia A Seale
Journal:  Nutrients       Date:  2016-02-06       Impact factor: 5.717

6.  Selenium Kinetics in Humans Change Following 2 Years of Supplementation With Selenomethionine.

Authors:  Blossom H Patterson; Gerald F Combs; Philip R Taylor; Kristine Y Patterson; James E Moler; Meryl E Wastney
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

7.  Absorption, excretion, and retention of selenium from a high selenium yeast in men with a high intake of selenium.

Authors:  Susanne Bügel; Erik H Larsen; Jens J Sloth; Knut Flytlie; Kim Overvad; Lars C Steenberg; Sven Moesgaard
Journal:  Food Nutr Res       Date:  2008-02-12       Impact factor: 3.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.